Restrictions are to be placed on the use of drugs containing high doses of nomegestrol or chlormadinone in the EU after the European Medicines Agency concluded that these medicines, which are used to treat gynecological disorders, can increase the risk of meningioma.
In addition, the EMA has started an urgent review of the safety of the cough suppressant, pholcodine, as well as...